306 related articles for article (PubMed ID: 30173152)
21. 2017 American College of Rheumatology/American Association of Hip and Knee Surgeons Guideline for the Perioperative Management of Antirheumatic Medication in Patients With Rheumatic Diseases Undergoing Elective Total Hip or Total Knee Arthroplasty.
Goodman SM; Springer B; Guyatt G; Abdel MP; Dasa V; George M; Gewurz-Singer O; Giles JT; Johnson B; Lee S; Mandl LA; Mont MA; Sculco P; Sporer S; Stryker L; Turgunbaev M; Brause B; Chen AF; Gililland J; Goodman M; Hurley-Rosenblatt A; Kirou K; Losina E; MacKenzie R; Michaud K; Mikuls T; Russell L; Sah A; Miller AS; Singh JA; Yates A
J Arthroplasty; 2017 Sep; 32(9):2628-2638. PubMed ID: 28629905
[TBL] [Abstract][Full Text] [Related]
22. 2017 American College of Rheumatology/American Association of Hip and Knee Surgeons Guideline for the Perioperative Management of Antirheumatic Medication in Patients With Rheumatic Diseases Undergoing Elective Total Hip or Total Knee Arthroplasty.
Goodman SM; Springer B; Guyatt G; Abdel MP; Dasa V; George M; Gewurz-Singer O; Giles JT; Johnson B; Lee S; Mandl LA; Mont MA; Sculco P; Sporer S; Stryker L; Turgunbaev M; Brause B; Chen AF; Gililland J; Goodman M; Hurley-Rosenblatt A; Kirou K; Losina E; MacKenzie R; Michaud K; Mikuls T; Russell L; Sah A; Miller AS; Singh JA; Yates A
Arthritis Rheumatol; 2017 Aug; 69(8):1538-1551. PubMed ID: 28620948
[TBL] [Abstract][Full Text] [Related]
23. Systemic lupus erythematosus: what should family physicians know in 2018?
Mok CC
Hong Kong Med J; 2018 Oct; 24(5):501-511. PubMed ID: 30262676
[TBL] [Abstract][Full Text] [Related]
24. The Pediatric Rheumatology International Trials Organization/American College of Rheumatology provisional criteria for the evaluation of response to therapy in juvenile systemic lupus erythematosus: prospective validation of the definition of improvement.
Ruperto N; Ravelli A; Oliveira S; Alessio M; Mihaylova D; Pasic S; Cortis E; Apaz M; Burgos-Vargas R; Kanakoudi-Tsakalidou F; Norambuena X; Corona F; Gerloni V; Hagelberg S; Aggarwal A; Dolezalova P; Saad CM; Bae SC; Vesely R; Avcin T; Foster H; Duarte C; Herlin T; Horneff G; Lepore L; van Rossum M; Trail L; Pistorio A; Andersson-Gäre B; Giannini EH; Martini A;
Arthritis Rheum; 2006 Jun; 55(3):355-63. PubMed ID: 16739203
[TBL] [Abstract][Full Text] [Related]
25. Canadian Rheumatology Association Recommendations for the Screening, Monitoring, and Treatment of Juvenile Idiopathic Arthritis-Associated Uveitis.
Berard R; Ng HY; Human A; Piskin D; Dhalla M; Gottlieb C; Batthish M; Chédeville G; Forest C; Fortin E; Gardiner J; Gerhold K; Jastrzebski A; Lang B; Miettunen PMH; Morgenstern S; Morin MP; Rosenberg A; Rumsey DG; Solarte CE; Tehrani N; Duffy KW; Pardo JP; Hazlewood GS; Levy DM
J Rheumatol; 2023 Mar; 50(3):390-399. PubMed ID: 36243417
[TBL] [Abstract][Full Text] [Related]
26. Rheumatologists' perception of systemic lupus erythematosus quality indicators: significant interest and perceived barriers.
Casey C; Chung CP; Crofford LJ; Barnado A
Clin Rheumatol; 2017 Jan; 36(1):97-102. PubMed ID: 27878408
[TBL] [Abstract][Full Text] [Related]
27. Association of clinic setting with quality indicator performance in systemic lupus erythematosus: a cross-sectional study.
Sreedharan S; Li N; Littlejohn G; Buchanan R; Nikpour M; Morand E; Hoi A; Golder V
Arthritis Res Ther; 2022 Jun; 24(1):150. PubMed ID: 35733186
[TBL] [Abstract][Full Text] [Related]
28. Evidence-based Recommendations for the Management of Comorbidities in Rheumatoid Arthritis, Psoriasis, and Psoriatic Arthritis: Expert Opinion of the Canadian Dermatology-Rheumatology Comorbidity Initiative.
Roubille C; Richer V; Starnino T; McCourt C; McFarlane A; Fleming P; Siu S; Kraft J; Lynde C; Pope J; Gulliver W; Keeling S; Dutz J; Bessette L; Bissonnette R; Haraoui B
J Rheumatol; 2015 Oct; 42(10):1767-80. PubMed ID: 26178281
[TBL] [Abstract][Full Text] [Related]
29. Systemic lupus erythematosus: a review of the disease and treatment options.
Gurevitz SL; Snyder JA; Wessel EK; Frey J; Williamson BA
Consult Pharm; 2013 Feb; 28(2):110-21. PubMed ID: 23395811
[TBL] [Abstract][Full Text] [Related]
30. Development of quality indicators to evaluate the monitoring of SLE patients in routine clinical practice.
Mosca M; Tani C; Aringer M; Bombardieri S; Boumpas D; Cervera R; Doria A; Jayne D; Khamashta MA; Kuhn A; Gordon C; Petri M; Schneider M; Shoenfeld Y; Smolen JS; Talarico R; Tincani A; Ward MM; Werth VP; Carmona L
Autoimmun Rev; 2011 May; 10(7):383-8. PubMed ID: 21224016
[TBL] [Abstract][Full Text] [Related]
31. Safety issues and recommendations for successful pregnancy outcome in systemic lupus erythematosus.
Nahal SK; Selmi C; Gershwin ME
J Autoimmun; 2018 Sep; 93():16-23. PubMed ID: 30056945
[TBL] [Abstract][Full Text] [Related]
32. Evaluation of quality indicators and disease damage in childhood-onset systemic lupus erythematosus patients.
Harris JG; Maletta KI; Kuhn EM; Olson JC
Clin Rheumatol; 2017 Feb; 36(2):351-359. PubMed ID: 28013435
[TBL] [Abstract][Full Text] [Related]
33. The chronic damage in systemic lupus erythematosus is driven by flares, glucocorticoids and antiphospholipid antibodies: results from a monocentric cohort.
Conti F; Ceccarelli F; Perricone C; Leccese I; Massaro L; Pacucci VA; Truglia S; Miranda F; Spinelli FR; Alessandri C; Valesini G
Lupus; 2016 Jun; 25(7):719-26. PubMed ID: 26821965
[TBL] [Abstract][Full Text] [Related]
34. 2017 American College of Rheumatology/American Association of Hip and Knee Surgeons Guideline for the Perioperative Management of Antirheumatic Medication in Patients With Rheumatic Diseases Undergoing Elective Total Hip or Total Knee Arthroplasty.
Goodman SM; Springer B; Guyatt G; Abdel MP; Dasa V; George M; Gewurz-Singer O; Giles JT; Johnson B; Lee S; Mandl LA; Mont MA; Sculco P; Sporer S; Stryker L; Turgunbaev M; Brause B; Chen AF; Gililland J; Goodman M; Hurley-Rosenblatt A; Kirou K; Losina E; MacKenzie R; Michaud K; Mikuls T; Russell L; Sah A; Miller AS; Singh JA; Yates A
Arthritis Care Res (Hoboken); 2017 Aug; 69(8):1111-1124. PubMed ID: 28620917
[TBL] [Abstract][Full Text] [Related]
35. EULAR recommendations for the management of systemic lupus erythematosus. Report of a Task Force of the EULAR Standing Committee for International Clinical Studies Including Therapeutics.
Bertsias G; Ioannidis JP; Boletis J; Bombardieri S; Cervera R; Dostal C; Font J; Gilboe IM; Houssiau F; Huizinga T; Isenberg D; Kallenberg CG; Khamashta M; Piette JC; Schneider M; Smolen J; Sturfelt G; Tincani A; van Vollenhoven R; Gordon C; Boumpas DT;
Ann Rheum Dis; 2008 Feb; 67(2):195-205. PubMed ID: 17504841
[TBL] [Abstract][Full Text] [Related]
36. The American College of Rheumatology response criteria for systemic lupus erythematosus clinical trials: measures of overall disease activity.
American College of Rheumatology Ad Hoc Committee on Systemic Lupus Erythematosus Response Criteria
Arthritis Rheum; 2004 Nov; 50(11):3418-26. PubMed ID: 15529383
[TBL] [Abstract][Full Text] [Related]
37. Role of specialty care in the management of patients with systemic lupus erythematosus.
Urowitz MB; Kagal A; Rahman P; Gladman DD
J Rheumatol; 2002 Jun; 29(6):1207-10. PubMed ID: 12064836
[TBL] [Abstract][Full Text] [Related]
38. Impact of systemic lupus erythematosus on oral health-related quality of life.
Corrêa JD; Branco LGA; Calderaro DC; Mendonça SMS; Travassos DV; Ferreira GA; Teixeira AL; Abreu LG; Silva TA
Lupus; 2018 Feb; 27(2):283-289. PubMed ID: 28679308
[TBL] [Abstract][Full Text] [Related]
39. Belimumab use, clinical outcomes and glucocorticoid reduction in patients with systemic lupus erythematosus receiving belimumab in clinical practice settings: results from the OBSErve Canada Study.
Touma Z; Sayani A; Pineau CA; Fortin I; Matsos M; Ecker GA; Chow A; Iczkovitz S
Rheumatol Int; 2017 Jun; 37(6):865-873. PubMed ID: 28280970
[TBL] [Abstract][Full Text] [Related]
40. First Latin American clinical practice guidelines for the treatment of systemic lupus erythematosus: Latin American Group for the Study of Lupus (GLADEL,
Pons-Estel BA; Bonfa E; Soriano ER; Cardiel MH; Izcovich A; Popoff F; Criniti JM; Vásquez G; Massardo L; Duarte M; Barile-Fabris LA; García MA; Amigo MC; Espada G; Catoggio LJ; Sato EI; Levy RA; Acevedo Vásquez EM; Chacón-Díaz R; Galarza-Maldonado CM; Iglesias Gamarra AJ; Molina JF; Neira O; Silva CA; Vargas Peña A; Gómez-Puerta JA; Scolnik M; Pons-Estel GJ; Ugolini-Lopes MR; Savio V; Drenkard C; Alvarellos AJ; Ugarte-Gil MF; Babini A; Cavalcanti A; Cardoso Linhares FA; Haye Salinas MJ; Fuentes-Silva YJ; Montandon de Oliveira E Silva AC; Eraso Garnica RM; Herrera Uribe S; Gómez-Martín D; Robaina Sevrini R; Quintana RM; Gordon S; Fragoso-Loyo H; Rosario V; Saurit V; Appenzeller S; Dos Reis Neto ET; Cieza J; González Naranjo LA; González Bello YC; Collado MV; Sarano J; Retamozo S; Sattler ME; Gamboa-Cárdenas RV; Cairoli E; Conti SM; Amezcua-Guerra LM; Silveira LH; Borba EF; Pera MA; Alba Moreyra PB; Arturi V; Berbotto GA; Gerling C; Gobbi CA; Gervasoni VL; Scherbarth HR; Brenol JCT; Cavalcanti F; Costallat LTL; Da Silva NA; Monticielo OA; Seguro LPC; Xavier RM; Llanos C; Montúfar Guardado RA; Garcia de la Torre I; Pineda C; Portela Hernández M; Danza A; Guibert-Toledano M; Reyes GL; Acosta Colman MI; Aquino AM; Mora-Trujillo CS; Muñoz-Louis R; García Valladares I; Orozco MC; Burgos PI; Betancur GV; Alarcón GS;
Ann Rheum Dis; 2018 Nov; 77(11):1549-1557. PubMed ID: 30045853
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
